Mmetụta mgbochi ọrịa cancer nke paclitaxel

Paclitaxel (Paclitaxel) bụ ọgwụ nwere usoro dị mgbagwoju anya ewepụtara site na osisi okike, yana ihe pụrụ iche na-egbochi ọrịa kansa na-eme ka ọ nwee ọtụtụ ngwa na ngalaba ahụike.Otú ọ dị, n'ihi na ya ụkọ na ike nke mmịpụta, mmepụta nkepaclitaxelabụrụla ihe ịma aka.N'ime afọ ndị na-adịbeghị anya, site na mgbalị ndị French chemists, ihe a na-akpọ 10-DAB dịpụrụ adịpụ nke ọma na akwụkwọ nke British purple, nke usoro ya yiri paclitaxel na ọdịnaya ya dị elu, nke na-enye ohere iji dozie nsogbu a.

Ọrụ nke paclitaxel

Dị ka ọgwụ mgbochi ọrịa cancer, isi ihe nke paclitaxel na-eme bụ ime ihe mgbochi tumor site na igbochi nkewa cell tumor.Ọ bụ ihe mgbochi microtubule, nke nwere ike ịkwalite polymerization nke tubulin ma gbochie ya depolymerization, si otú ahụ na-egbochi mitosis nke mkpụrụ ndụ tumo.Na mgbakwunye, paclitaxel nwekwara ike ịkpalite apoptosis tumor cell site na ịgbalite usoro ahụ ji alụso ọrịa ọgụ.

2. Ngwa mpaghara nkepaclitaxel

1. Ọgwụgwọ Tumor: Paclitaxel bụ nke a na-ejikarị eme ihe n'ihe gbasara ọgwụgwọ etuto ahụ, ọkachasị maka etuto ọjọọ dị ka ọrịa ara ara, ọrịa ovarian na ọrịa kansa akpa ume.Enwere ike iji ya naanị ma ọ bụ jikọtara ya na ọgwụ ndị ọzọ na-egbochi ọrịa cancer iji melite irè ọgwụgwọ.

2, ngalaba ahụike ndị ọzọ: Na mgbakwunye na ọgwụgwọ tumor,paclitaxela na-ejikwa ya na ngalaba ahụike ndị ọzọ.Dịka ọmụmaatụ, enwere ike iji ya mee ka eze ma ọ bụ orthopedic jupụta, a pụkwara iji ya gwọọ ụfọdụ ọrịa autoimmune na ọrịa akwara ozi.

Rịba ama: A na-enweta uru na ngwa ndị nwere ike ime n'isiokwu a site na akwụkwọ ndị e bipụtara.

Yunnan Hande Biotechnology Co., Ltd. lekwasịrị anya na mmepụta nke paclitaxel ruo afọ 26, na ọ bụ onye nrụpụta onwe ya nke ọgwụ paclitaxel API nke United States FDA kwadoro, European EDQM, Australia TGA, China CFDA. , India, Japan na ndị ọzọ na-ahụ maka nchịkwa mba.Yunnan Hande paclitaxel, ntụpọ ọkọnọ, ụlọ ọrụ na-ere ahịa ozugbo, nabata ịjụ, 18187887160 (WhatsApp otu nọmba)